Motivista (CT-155)

FDA 510(k) K254038 · Click Therapeutics, Inc.

Substantially Equivalent

510(k) numberK254038

Submission

Device name
Motivista (CT-155)
Applicant
Click Therapeutics, Inc.
New York, NY, US
Received
December 16, 2025
Decision date
July 30, 2026
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
SAP – Computerized Behavioral Therapy Device For Depressive Disorders.
Device class
Class II (moderate risk)
Regulation
21 CFR 882.5801
Specialty
Neurology

The device is intended to provide computerized behavioral therapy to treat depressive disorders.

Other 510(k)s with product code SAP

510(k)DeviceApplicantDecision
K223515MamaLift PlusSAP · Traditional Curio Digital Therapeutics, Inc.04/22/2024SE
K231209RejoynSAP · Traditional Otsuka America Pharmaceutical, Inc.03/30/2024SE

Questions and answers

When was Motivista (CT-155) cleared by the FDA?

Motivista (CT-155) (K254038) received a 510(k) decision of Substantially Equivalent on July 30, 2026, 226 days after the submission was received.

What is the product code of K254038?

The FDA product code is SAP – Computerized Behavioral Therapy Device For Depressive Disorders., a Class II (moderate risk) device regulated under 21 CFR 882.5801.